Emtricitabine + Tenofovir Alafenamide + Tenofovir Alafenamide Monofumarate

Fixed-dose combination

This page lists brands whose active-ingredient set is exactly the combination below. It is identity information only — a fixed-dose combination is not the same product as its single ingredients, and the brand names are not interchangeable across markets.

Not medical advice. Check the pack and the exact composition before comparing products; ask a pharmacist if unsure.

Active ingredients

Emtricitabine emtricitabine
Tenofovir Alafenamide tenofovir-alafenamide
Tenofovir Alafenamide Monofumarate tenofovir-alafenamide-monofumarate

Brands with this exact combination

Brand	Composition & strength	Manufacturer
Emtricitabine/Tenofovir alafenamide ViatrisCZ EU LV	tablet ×8 Emtricitabine 200 mg + Tenofovir Alafenamide Monofumarate tablet ×6 Emtricitabine 200 mg + Tenofovir Alafenamide 25 mg tablet ×2 Emtricitabine 200 mg + Tenofovir Alafenamide 10 mg unknown Emtricitabine + Tenofovir Alafenamide	VIATRIS LIMITED, Dublin

Same combination in other markets

Cross-market comparison is not available for this grouped name.

See warnings for these ingredients

Source & licence: built from the same regulator data as the ingredient pages (openFDA, dm+d, CIMA, COFEPRIS, PBS/TGA, Health Canada DPD, NHSA). Facts only; see the licence register.